Showing results (221-230 of 258) with videos related to

Sort By:
Pageof 26
Journal of Neuroinflammation|March 24, 2024
Inflammation-induced TRPV4 channels exacerbate blood-brain barrier dysfunction in multiple sclerosisCathrin E Hansen, Alwin Kamermans, Kevin Mol, et al.
Neuro-Oncology|May 24, 2026
Single-nucleus profiling of postmortem diffuse midline gliomas identifies mitochondrial biogenesis as a resistance mechanism to imipridone therapyMasahiro Okada, Bavani Subramaniam, Baobao Geng, et al.
Nucleic Acids Research|May 3, 2015
The transcriptional PPARβ/δ network in human macrophages defines a unique agonist-induced activation stateTill Adhikary, Annika Wortmann, Tim Schumann, et al.
Allergy|August 19, 2023
Efficacy and safety of on-demand versus daily rupatadine in chronic spontaneous urticaria: A randomized trialKarsten Weller, Ana Maria Gimenez-Arnau, Jens Baron, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|December 6, 2017
Honest, Open, Proud for adolescents with mental illness: pilot randomized controlled trialNadine Mulfinger, Sabine Müller, Isabel Böge, et al.
Molecular Oncology|April 22, 2022
Arachidonic acid, a clinically adverse mediator in the ovarian cancer microenvironment, impairs JAK-STAT signaling in macrophages by perturbing lipid raft structuresMohamad K Hammoud, Raimund Dietze, Jelena Pesek, et al.
Movement Disorders Clinical Practice|February 24, 2026
MDSGene Systematic Review of Common Forms of Dominant Hereditary Spastic Paraplegia: Novel InsightsCe Kang, Rajasumi Rajalingam, Zachary Walls, et al.
Molecular Oncology|June 14, 2020
Upregulation of mesothelial genes in ovarian carcinoma cells is associated with an unfavorable clinical outcome and the promotion of cancer cell adhesionKaire Ojasalu, Corinna Brehm, Kristin Hartung, et al.
Cell Communication and Signaling : CCS|March 14, 2025
Basal cell adhesion molecule (BCAM) promotes mesothelial-to-mesenchymal transition and tumor angiogenesis through paracrine signalingSuresh Sivakumar, Sonja Lieber, Raimund Dietze, et al.
The Journal of Allergy and Clinical Immunology|July 4, 2016
Predominant Api m 10 sensitization as risk factor for treatment failure in honey bee venom immunotherapyMarcel Frick, Jörg Fischer, Arthur Helbling, et al.
Pageof 26